Seres Therapeutics Inc
MCRB - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$20.78M
Close$
$-3.63
283.4% downside
Current Fair Value
283.4% downsideOvervalued by 283.4% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $20.78 Million |
|---|---|
| Enterprise Value | $61.83 Million |
| Earnings per Share | $0.64 |
| Beta | 0.22 |
| Outstanding Shares | 9,644,704 |
Return
| Return on Equity | -65.05% |
|---|---|
| Return on Assets | -22.11% |
| Return on Invested Capital | -103.99% |
Valuation & Multiples
| P/E Ratio | -0.88 |
|---|---|
| PEG | 0.71 |
| Price to Sales | - |
| Price to Book Ratio | 0.66 |
| Enterprise Value to Revenue | 32.83 |
| Enterprise Value to EBIT | -0.73 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.92 |
| Debt to Equity | 1.64 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
$-2.18
Consensus analyst estimateRevenue Estimate
$179,000
Consensus analyst estimateNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$-1.00
Consensus analyst estimateRevenue Estimate
$6.35 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 9.67, the ratio is above 1, so institutions hold more puts than calls. That is a more cautious stance.
| Put/Call Ratio | 9.6667▲ 747.27% |
|---|---|
| Total Calls | 11,100▼ 80.42% |
| Total Puts | 107,300▼ 13.75% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 23.90%▼ 0.17% |
|---|---|
| Total Invested | $18.19M▼ 11.09% |
| Investors Holding | 40▲ 4.00% |
About Seres Therapeutics Inc
CEO: Eric Shaff
